Puma Biotechnology Inc (PBYI) stock has risen 15.38% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives PBYI stock a score of 32 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 25. PBYI's rank also includes a fundamental score of 33. In addition to the average rating from Wall Street analysts, PBYI stock has a mean target price of 11.166. This means analysts expect the stock to lose 9.81% over the next 12 months. The short-term technical score for PBYI is 37.
What's Happening with PBYI Stock Today
Puma Biotechnology Inc (PBYI) stock is higher by 10.04% while the S&P 500 is unmoved 0% as of 9:48 AM on Tuesday, Dec 1. PBYI has risen $1.13 from the previous closing price of $11.25 on volume of 115,308 shares. Over the past year the S&P 500 is up 16.31% while PBYI has risen 15.38%. PBYI lost -$1.43 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Puma Biotechnology Inc (PBYI) Stock.
